| Key Financial Ratios of Zydus Lifesciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
57.39 |
34.01 |
15.06 |
8.38 |
14.42 |
|
| Diluted EPS (Rs.) |
57.39 |
34.01 |
15.06 |
8.38 |
14.42 |
|
| Cash EPS (Rs.) |
62.61 |
39.22 |
19.94 |
13.05 |
18.82 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
210.64 |
156.23 |
134.78 |
129.30 |
124.46 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
210.64 |
156.23 |
134.78 |
129.30 |
124.46 |
|
| Dividend / Share(Rs.) |
11.00 |
3.00 |
6.00 |
2.50 |
3.50 |
|
| Revenue from Operations/Share (Rs.) |
150.26 |
107.54 |
86.28 |
77.95 |
75.98 |
|
| PBDIT/Share (Rs.) |
83.82 |
51.13 |
29.67 |
20.48 |
23.42 |
|
| PBIT/Share (Rs.) |
78.61 |
46.11 |
24.84 |
15.80 |
19.01 |
|
| PBT/Share (Rs.) |
74.00 |
42.15 |
20.08 |
11.37 |
16.49 |
|
| Net Profit/Share (Rs.) |
57.40 |
34.21 |
15.11 |
8.38 |
14.42 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
55.78 |
47.54 |
34.39 |
26.26 |
30.82 |
|
| PBIT Margin (%) |
52.31 |
42.88 |
28.79 |
20.27 |
25.02 |
|
| PBT Margin (%) |
49.24 |
39.18 |
23.27 |
14.58 |
21.70 |
|
| Net Profit Margin (%) |
38.20 |
31.81 |
17.51 |
10.74 |
18.97 |
|
| Return on Networth / Equity (%) |
27.25 |
21.89 |
11.21 |
6.47 |
11.58 |
|
| Return on Capital Employed (%) |
32.32 |
21.53 |
14.14 |
11.80 |
14.27 |
|
| Return on Assets (%) |
17.86 |
14.28 |
7.43 |
4.83 |
7.99 |
|
| Total Debt/Equity (X) |
0.39 |
0.39 |
0.35 |
0.20 |
0.31 |
|
| Asset Turnover Ratio (%) |
0.54 |
0.48 |
0.46 |
0.44 |
0.44 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.95 |
3.12 |
2.57 |
1.70 |
1.25 |
|
| Quick Ratio (X) |
1.70 |
2.46 |
1.93 |
1.22 |
0.88 |
|
| Inventory Turnover Ratio (X) |
8.31 |
1.73 |
1.46 |
1.42 |
1.48 |
|
| Dividend Payout Ratio (NP) (%) |
5.22 |
17.64 |
16.54 |
41.78 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
4.79 |
15.39 |
12.53 |
26.82 |
0.00 |
|
| Earnings Retention Ratio (%) |
94.78 |
82.36 |
83.46 |
58.22 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
95.21 |
84.61 |
87.47 |
73.18 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
97,296.02 |
106,887.25 |
54,314.20 |
38,066.88 |
48,904.94 |
|
| EV/Net Operating Revenue (X) |
6.44 |
9.88 |
6.22 |
4.77 |
6.29 |
|
| EV/EBITDA (X) |
11.54 |
20.78 |
18.09 |
18.15 |
20.39 |
|
| MarketCap/Net Operating Revenue (X) |
5.89 |
9.35 |
5.70 |
4.47 |
5.80 |
|
| Retention Ratios (%) |
94.77 |
82.35 |
83.45 |
58.21 |
0.00 |
|
| Price/BV (X) |
4.20 |
6.43 |
3.65 |
2.70 |
3.54 |
|
| Price/Net Operating Revenue |
5.89 |
9.35 |
5.70 |
4.47 |
5.80 |
|
| Earnings Yield |
0.06 |
0.03 |
0.03 |
0.02 |
0.03 |
|
Source : Dion Global Solutions Limited
